Genmab — Marts 2020
-
Jeg tror at The Donald har en pointe i at samfundet ikke kan være lukket i ret lang tid. Økonomisk ruin koster også menneskeliv, så på et tidspunkt skal der laves en liste med pros and cons. Under nedlukningen skal der laves massive tiltag for at teste og efterfølgende behandle, og så skal der laves en plan for hvordan man åbner samfundet op igen. Det samme bør man gøre herhjemme (efter min mening), og i den forbindelse er det jo ekstra ærgerligt at vi sagde nej tak til de testkits.
-
Det er naturligvis et spørgsmål om timing og kapacitet, men værnemidler og restriktioner skal i langt højere grad være en del af vores hverdag indtil der kommer en vaccine.
-
(in English so E L can confirm if true or not). In The Netherlands supermarkets are opening up earlier so elderly people can shop before the rest of the customers, and it is prohibited for couples to shop together, in order to reduce the number of people in the shops. Those are simple measures which can stay in effect for a long time without major economic consequences.
-
Og nej, det er ikke for at redde værdien af mine aktier - det er blot et indspark til at alt har konsekvenser, og det vil det også have hvis økonomien går fuldstændig nedenom og hjem. Det er heller ikke nogen kritik af nedlukningsfilosofien, for det er vigtigt at stoppe/forsinke ulykken så man har tid til at planlægge det næste skridt på en fornuftig måde.
-
@Plimsoller , yes that is true, but you have to get up early, because it is between 7 and 8 am
More countries are trying this actually -
Ok, but especially the older men will be up at 5am anyway to got to the restroom
-
Jokes aside, it is a simple and practical measure, and more of those are needed in my opinion.
-
Sidder her i Vejle og er i gang med den 75. sekvens af DARA. Læste lige det link som EL 08:32 henviste til om subkutan vs IV. Som jeg lytter mig frem til vil tiden for subkutan være præmedicin 30 min + subkutan 5 min + observation 20 min, så ca en time mod 2,5-3 timerfor IV.
-
EMA agenda this week, Day 180 list of
outstanding issues: 4.2.1. Darzalex - daratumumab - Orphan - Scope: “Extension application to introduce a new pharmaceutical form (solution for
injection), a new strength (1800 mg) and a new route of administration (subcutaneous
route).”
Action: For adoption -
i don't think so, probably more questions for JNJ
https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/evaluation-medicines-step-step -but i would be happy to be wrong here... -
God morgen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind